跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg - TGA Drug Approval Details
Approvals
/
TGA
/
Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg
Approved
STANDARD
Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg
Hospira Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d91c1fa836d295f8
Company
Hospira Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d91c1fa836d295f8
Product Name
Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg
Artg Id
205417
Artg Name
Hospira irinotecan hydrochloride trihydrate IV Infusion 40 mg
Sponsor
Hospira Australia Pty Ltd
Company Detail Path
/organization/hospira-australia-pty-ltd
Artg Date
2013-01-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d91c1fa836d295f8
Type
Standard
Back to TGA Approvals
